WASHINGTON (MedPage Today) -- The FDA alerted healthcare professionals that the HIV medication etravirine (Intelence) may cause severe skin reactions, and the manufacturer has updated the drug's label accordingly.
FDA Warns of Increased Danger with HIV DrugCourtesy MedPage Today Infectious Disease Sat, 08/29/2009 - 15:10
WASHINGTON (MedPage Today) -- The FDA alerted healthcare professionals that the HIV medication etravirine (Intelence) may cause severe skin reactions, and the manufacturer has updated the drug's label accordingly. More related itemsICAAC: New Drug Easier to Take than HIV Standard...
Untreated HIV Patients Have New Drug Option (CME/CE)
ACTHIV: Etravirine Better in Less Treated Patients...
The Unwritten Rules of Friendship: Simple Strategies...
|
Post new comment